Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy

Figure 1

Comparison of normalised median expression levels of VEGFR-1 , VEGFR-2 and TKTL1 in tumour and healthy mucosa. Comparison of normalised median expression levels of VEGFR-1 (VEGFR-1/GUS), VEGFR-2 (VEGFR-2/GUS) and TKTL1 (TKTL1/GUS) in tumour and healthy mucosa before (A1, B1) and after neoadjuvant treatment (A2; B2) (Box and whiskers plot, 10-90th percentile). A1: normal mucosa before neoadjuvant chemoradiotherapy; A2: normal mucosa after neoadjuvant chemoradiotherapy; B1 tumour tissue before neoadjuvant chemoradiotherapy; B2: tumour tissue after neoadjuvant chemoradiotherapy;

Back to article page